In conclusion, we found genetic polymorphisms in rs3814055 in PXR and rs78872571 and rs4647992 in NF-κB1 that were associated with susceptibility to ATDILI resulting from first-line anti-tuberculosis combination treatment in a Chinese population. The gene discussed is NFKB1; the disease is tuberculosis.